# Anticancer research

Source: https://onco.cc/journals/anticancer-research/  
OnCo record `anticancer-research` (Journal). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

Anticancer Research is a monthly journal from the International Institute of Anticancer Research in Greece that has published experimental and clinical cancer papers with fast turnaround since 1981. It is indexed in MEDLINE, but its access model is mixed and it is not listed in DOAJ, so check individual articles.

## Summary

Anticancer Research is published from Kapandriti, Attica, Greece, by the International Institute of Anticancer Research (IIAR), which describes it as an international print and online monthly journal designed to rapidly publish peer-reviewed original works and reviews on all aspects of experimental and clinical cancer research, established in 1981. It is one of four IIAR journals alongside In Vivo, Cancer Genomics & Proteomics and Cancer Diagnosis & Prognosis. The current issue lists individual articles labelled Open Access alongside others, and the journal is not listed in DOAJ, so no single access model is recorded here. Indexed in MEDLINE.

## Fields

- Kind: Journal
- Last checked: 2026-09-10
- Also known as: Anticancer Research; Anticancer Res
- Publisher: International Institute of Anticancer Research
- Scope: experimental and clinical cancer research

## Sources

- Homepage: https://ar.iiarjournals.org/
- NLM Catalog: https://www.ncbi.nlm.nih.gov/nlmcatalog/8102988

## Connected records

- collections: [PubMed & Europe PMC](https://onco.cc/collections/pubmed-europepmc/)
- journals: [Cancer genomics & proteomics](https://onco.cc/journals/cancer-genomics-and-proteomics/), [In vivo](https://onco.cc/journals/in-vivo/)
- people: [Igor Kiss](https://onco.cc/people/igor-kiss/)
- key papers: [Real-world clinical outcomes of ivermectin and mebendazole in cancer patients: results from a prospective observational cohort (with 2026 expression of concern)](https://onco.cc/key-papers/paper-hulscher-ivermectin-mebendazole-cohort-anticancer-res-2026/)

---
JSON: https://onco.cc/api/v1/entities/anticancer-research.json